| PERIOD ENDING | 4-Oct-09 | 5-Jul-09 | 5-Apr-09 | 31-Dec-08 | | Total Revenue | 7,719,000 | 8,100,000 | 8,264,000 | 7,852,000 | | Cost of Revenue | 7,864,000 | 6,646,000 | 6,849,000 | 6,490,000 | | | Gross Profit | (145,000) | 1,454,000 | 1,415,000 | 1,362,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (1,019,000) | 509,000 | 510,000 | 424,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 874,000 | 945,000 | 905,000 | 938,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (6,000) | (3,000) | 6,000 | 25,000 | | Earnings Before Interest And Taxes | 751,000 | 942,000 | 911,000 | 963,000 | | Interest Expense | (77,000) | 35,000 | 42,000 | 35,000 | | Income Before Tax | 828,000 | 907,000 | 869,000 | 928,000 | | Income Tax Expense | 253,000 | 286,000 | 276,000 | 298,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 575,000 | 621,000 | 593,000 | 630,000 | | | Non-recurring Events | | Discontinued Operations | (3,000) | (3,000) | (3,000) | (18,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 572,000 | 618,000 | 590,000 | 612,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $572,000 | $618,000 | $590,000 | $612,000 |
|
0.03% Nasdaq 0.00%
Income Statement
